Armistice Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131M | Buy |
|
|||||
|
2025
Q1 | $159M | Buy |
|
|||||
|
2024
Q4 | $128M | Sell |
|
|||||
|
2024
Q3 | $107M | Buy |
|
|||||
|
2024
Q2 | $61.6M | Hold |
|
|||||
|
2024
Q1 | $57.8M | Buy |
|
|||||
|
2023
Q4 | $66.4M | Sell |
|
|||||
|
2023
Q3 | $67M | Buy |
|
|||||
|
2023
Q2 | $114M | Buy |
|
|||||
|
2023
Q1 | $161M | Buy |
|
|||||
|
2022
Q4 | $135M | Buy |
|
|||||
|
2022
Q3 | $144M | Buy |
|
|||||
|
2022
Q2 | $129K | Buy |
|
|||||
|
2022
Q1 | $128M | Buy |
|
|||||
|
2021
Q4 | $127M | Sell |
|
|||||
|
2021
Q3 | $115M | Sell |
|
|||||
|
2021
Q2 | $83.9M | Buy |
|
|||||
|
2021
Q1 | $58.8M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $427K | Buy |
|